Navigation Links
Women altering menstruation cycles in large numbers, UO study shows
Date:5/9/2013

EUGENE, Ore. -- A surprisingly large number of women 18 or older choose to delay or skip monthly menstruation by deviating from the instructions of birth-control pills and other hormonal contraceptives, a team of University of Oregon researchers and others found in a study of female students at the university.

Most women who alter bleeding cycles do so for convenience rather than to avoid menstrual symptoms, and many learn about the option from nonmedical sources, according to research by the university's Department of Human Physiology, Portland-based Oregon Health and Sciences University and Eastern Michigan University. The study is published in Contraception, the official journal of the Association of Reproductive Health Professionals and the Society of Family Planning.

"These findings emphasize the need for health care providers to carefully interview combined hormonal contraceptive users on how they are using their method for example, many women may be skipping pills to extend their cycles," said researcher Christopher Minson, a human physiology professor at the University of Oregon. "With a greater understanding of the issues, health care providers may be able to more effectively engage in conversations with college-aged women and educate them about available options."

As research indicates that reducing the occurrence of menstruation is safe and can even be beneficial, women are increasingly using hormonal contraceptives to alter bleeding cycles. But there has been a lack of information concerning why women do so and from whom they receive information regarding this option.

In a survey of undergraduate and graduate students, 17 percent reported altering their scheduled bleeding pattern by deviating from the instructions of hormonal contraceptives, which include birth-control pills, vaginal contraceptive rings and transdermal contraceptive patches.

Half of these women reported that they did so for convenience or scheduling purposes. Others cited personal preference (28.9 percent) or reducing menstrual symptoms (16.7 percent) as reasons they altered menstruation patterns.

Among the women who delayed or skipped a scheduled bleeding for convenience or personal choice, a comparatively large number 53 percent indicated the knowledge was obtained from nonmedical sources, such as a family member or friend, researchers said.

The survey also provides new insights on the factors that influence a woman's decision whether to alter bleeding schedules. Asians have a 7 percent lower probability of altering hormonal cycles and women who exercise regularly have a 5 percent lower probability of doing so; another characteristic that decreased the likelihood of the practice was preference for a monthly cycle.

"We found that it is possible to identify some of the specific characteristics of women in a college population who may be more or less likely to practice scheduled bleeding manipulation," said Dr. Paul Kaplan, of the University Health Center and Oregon Health and Sciences University. "This study provides information about the motives, beliefs and influences relating to this practice."

In a finding that surprised researchers, women who said they would prefer no menstrual periods were less likely to alter their cycles than those who would prefer one per year. A woman who would prefer one cycle per year had a 17 percent higher probability of modifying her hormonal contraceptive regimen than one who preferred a menstrual period every three months or never.

This suggests that health care providers could improve education of the hormonal contraception regimen best-suited to a patient's needs and desires, researchers said.

From an estimated 11,900 survey-linked emails sent to female university students, 1,719 (14.4 percent) initial responses were received and 1,374 (79.9 percent of respondents) indicated that they had used a combined hormonal contraceptive during the last six months.


'/>"/>

Contact: Matt Cooper
mattc@uoregon.edu
541-346-8875
University of Oregon
Source:Eurekalert

Related biology news :

1. Brain anatomy of dyslexia is not the same in men and women, boys and girls
2. Elseviers Maturitas publishes clinical guide on endometrial assessment in postmenopausal women
3. Shared Medical Resources, LLC files suit against Histologics, LLC, Womens Health Laboratories and Avero Diagnostics for Willful Patent Infringement
4. Pregnant women with high celiac disease antibodies are at risk for low birth weight babies
5. Women with HIV shown to have elevated resting energy expenditure
6. Inter-American Network of Science Academies celebrates women scientists -- April 17 event
7. Study reveals risk factors for blood clots in pregnant and postnatal women
8. Men and women get sick in different ways
9. European Guidance for the diagnosis & management of osteoporosis in postmenopausal women
10. Stereotyping prime obstacle to women in commercial science
11. New book celebrates women scientists in the Americas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/1/2016)... June 1, 2016 Favorable Government ... Administration and Criminal Identification to Boost Global Biometrics System ... released TechSci Research report, " Global Biometrics Market ... Forecast and Opportunities, 2011 - 2021", the global biometrics ... 2021, on account of growing security concerns across various ...
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® Inc. (RCA), ... free webinar on Performing Quality Investigations: Getting to Root Cause. ... no charge. , Incomplete investigations are still a major concern to the Regulatory ...
Breaking Biology Technology: